Published in Proc Natl Acad Sci U S A on August 04, 2005
Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47
Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell (2011) 2.39
INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res (2008) 2.31
Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol (2006) 1.82
USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS One (2011) 1.60
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat Immunol (2013) 1.41
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev (2012) 1.38
Type I interferon in the pathogenesis of lupus. J Immunol (2014) 1.29
Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J Virol (2007) 1.28
Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood (2009) 1.18
MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One (2012) 1.06
Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci Signal (2014) 1.04
Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains. Infect Immun (2008) 0.99
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb) (2013) 0.97
Osteoclastogenesis and arthritis. Clin Exp Med (2010) 0.93
Should we inhibit type I interferons in sepsis? Infect Immun (2006) 0.92
Cell-cell fusion induced by measles virus amplifies the type I interferon response. J Virol (2007) 0.92
Effects of particle size on toll-like receptor 9-mediated cytokine profiles. Biomaterials (2010) 0.92
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res (2015) 0.90
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. J Cell Biol (2015) 0.88
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types. Front Immunol (2014) 0.85
Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells. Mol Carcinog (2012) 0.85
Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets. PLoS One (2012) 0.85
TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses. Cell Death Differ (2012) 0.83
Assessment of bone remodelling in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) (2010) 0.80
Fine Tuning of a Type 1 Interferon Antagonist. PLoS One (2015) 0.79
Role of RANKL (TNFSF11)-dependent osteopetrosis in the dental phenotype of Msx2 null mutant mice. PLoS One (2013) 0.78
Negative autoregulation of RANKL and c-Src signaling in osteoclasts. J Bone Miner Metab (2007) 0.77
Differential activity of type I interferon subtypes for dendritic cell differentiation. PLoS One (2013) 0.77
Listr1 locus regulates innate immunity against Listeria monocytogenes infection in the mouse liver possibly through Cxcl11 polymorphism. Immunogenetics (2014) 0.76
Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology (2014) 0.76
Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro. Nutrients (2015) 0.75
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development. Curr Mol Med (2016) 0.75
The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond. Front Immunol (2017) 0.75
A hot-spot on interferon alpha/beta receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling. J Biol Chem (2017) 0.75
Impairment of human neural crest cell migration by prolonged exposure to interferon-beta. Arch Toxicol (2017) 0.75
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Genetic regulation of osteoclast development and function. Nat Rev Genet (2003) 7.94
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med (1998) 4.52
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature (2002) 4.44
Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol (2004) 3.25
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest (2000) 1.97
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem (1996) 1.92
Different pathways mediate virus inducibility of the human IFN-alpha 1 and IFN-beta genes. Cell (1990) 1.91
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol (2004) 1.88
Signaling pathways activated by interferons. Exp Hematol (1999) 1.85
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res (2003) 1.82
Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr Opin Immunol (2003) 1.78
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta (2004) 1.57
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev (2004) 1.46
Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol (2003) 1.43
Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood (2002) 1.31
Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J Biol Chem (1996) 1.27
Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. J Biol Chem (2000) 1.24
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem (2003) 1.21
Shared receptor components but distinct complexes for alpha and beta interferons. J Mol Biol (1998) 1.20
Down-modulation of responses to type I IFN upon T cell activation. J Immunol (2003) 1.17
Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J Immunol (2004) 1.12
Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J Interferon Cytokine Res (2002) 1.11
Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J Biol Chem (1998) 1.11
The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J Interferon Cytokine Res (2002) 1.10
The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J Immunol (2003) 1.06
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol (2001) 1.06
Endogenous type I interferons as a defense against tumors. Cytokine Growth Factor Rev (2002) 1.03
Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum (2004) 1.03
IFN-alpha subtypes differentially affect human T cell motility. J Immunol (2004) 1.02
Diversity and relatedness among the type I interferons. J Interferon Cytokine Res (2004) 1.01
Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene. J Biol Chem (2002) 0.93
CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. Genes Immun (2004) 0.92
I-TAC/CXCL11 is a natural antagonist for CCR5. J Leukoc Biol (2004) 0.91
Biologic role of interferon beta in multiple sclerosis. J Neurol (2004) 0.87
Independent origin of IFN-alpha and IFN-beta in birds and mammals. J Interferon Cytokine Res (2000) 0.85
Stat1-mediated cytoplasmic attenuation in osteoimmunology. J Cell Biochem (2005) 0.85
Type I interferon genes from the egg-laying mammal, Tachyglossus aculeatus (short-beaked echidna). Immunol Cell Biol (2004) 0.78
Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol (2004) 3.25
N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts. J Cell Biol (2002) 2.29
The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth. Curr Biol (2002) 1.87
Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO. Curr Biol (2004) 1.87
The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. Proc Natl Acad Sci U S A (2008) 1.85
Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood (2006) 1.76
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J (2003) 1.75
Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol (2006) 1.75
Biogenesis of N-cadherin-dependent cell-cell contacts in living fibroblasts is a microtubule-dependent kinesin-driven mechanism. Mol Biol Cell (2002) 1.74
Differential receptor subunit affinities of type I interferons govern differential signal activation. J Mol Biol (2006) 1.67
USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS One (2011) 1.60
Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. Biochemistry (2003) 1.51
Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol (2002) 1.42
RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol Biol Cell (2005) 1.40
Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther (2005) 1.37
Rho GTPases in osteoclasts: orchestrators of podosome arrangement. Eur J Cell Biol (2008) 1.25
Receptor density is key to the alpha2/beta interferon differential activities. Mol Cell Biol (2009) 1.22
CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology (2003) 1.19
Down-modulation of responses to type I IFN upon T cell activation. J Immunol (2003) 1.17
A cell active chemical GEF inhibitor selectively targets the Trio/RhoG/Rac1 signaling pathway. Chem Biol (2009) 1.15
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J (2007) 1.14
Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells. Mol Biol Cell (2007) 1.12
Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. J Mol Biol (2005) 1.12
The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J Immunol (2004) 1.10
USP18 establishes the transcriptional and anti-proliferative interferon α/β differential. Biochem J (2012) 1.09
Self-controlled monofunctionalization of quantum dots for multiplexed protein tracking in live cells. Angew Chem Int Ed Engl (2010) 1.07
Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts. J Bone Miner Res (2006) 1.06
Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression. J Leukoc Biol (2006) 1.03
The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J Bone Miner Res (2011) 1.02
The GTP/GDP cycling of rho GTPase TCL is an essential regulator of the early endocytic pathway. Mol Biol Cell (2003) 0.98
The DH-PH region of the giant protein UNC-89 activates RHO-1 GTPase in Caenorhabditis elegans body wall muscle. J Mol Biol (2008) 0.95
Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration. Biol Cell (2007) 0.95
The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int J Biochem Cell Biol (2008) 0.95
Induction of lamellipodia by Kalirin does not require its guanine nucleotide exchange factor activity. Exp Cell Res (2005) 0.93
CD40/CD154 ligation is required for the development of acute ileitis following oral infection with an intracellular pathogen in mice. Gastroenterology (2002) 0.81
Podosomes are dispensable for osteoclast differentiation and migration. Eur J Cell Biol (2013) 0.78
Differential activity of type I interferon subtypes for dendritic cell differentiation. PLoS One (2013) 0.77
Promyelocytic leukemia zinc-finger induction signs mesenchymal stem cell commitment: identification of a key marker for stemness maintenance? Stem Cell Res Ther (2014) 0.77